Francesc B.
- Country
- Spain
- Department
- Hematology
Research Overview
- Dose-Escalation and Expansion Study of BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein Degrader, in Patients with B-Cell Malignancies
- A Phase 3, Randomized Study to Compare Nemtabrutinib Versus Comparator (Investigator’s Choice of Ibrutinib or Acalabrutinib) in Participants With Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BELLWAVE-011)
- Phase 3 Randomized Study of Nemtabrutinib Versus Investigator’s Choice of Ibrutinib or Acalabrutinib in Untreated CLL/SLL
Data & Insights
Has run more than one trial at 84 of 254 partner sites.
Specializations
Lymphoma Research
Specializes in treating various forms of B-cell lymphomas, with particular emphasis on diffuse large B-cell lymphoma and Non-Hodgkin's lymphoma. Investigates novel therapeutic approaches including targeted immunotherapies and combination treatments.
- Aggressive B-cell lymphomas
- Follicular lymphoma
- Peripheral T-cell lymphoma
Explores innovative treatment combinations involving chemotherapy regimens and targeted antibody therapies.
Leukemia Studies
Focuses on advancing treatment options for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Evaluates novel therapeutic agents and their combinations in both treatment-naive and relapsed/refractory settings.
- BTK inhibitor therapies
- Venetoclax-based combinations
- MRD-guided treatment approaches
Investigates personalized treatment strategies based on molecular markers and disease characteristics.
Novel Therapeutics
Leads research in targeted cancer therapies and immunotherapy approaches, including evaluation of new drug candidates and innovative treatment combinations.
- Monoclonal antibody therapies
- BTK-targeted compounds
- Cancer vaccines
Explores cutting-edge therapeutic modalities for hematologic malignancies with focus on precision medicine approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.